title: The prevention and regression of atherosclerotic plaques: emerging treatments.
abstract: Occlusive vascular diseases, such as sudden coronary syndromes, stroke, and peripheral arterial disease, are a huge burden on the health care systems of developed and developing countries. Tremendous advances have been made over the last few decades in the diagnosis and treatment of atherosclerotic diseases. Intravascular ultrasound has been able to provide detailed information of plaque anatomy and has been used in several studies to assess outcomes. The presence of atherosclerosis disrupts the normal protective mechanism provided by the endothelium and this mechanism has been implicated in the pathophysiology of coronary artery disease and stroke. Efforts are being put into the prevention of atherosclerosis, which has been shown to begin in childhood. This paper reviews the pathophysiology of atherosclerosis and discusses the current options available for the prevention and reversal of plaque formation.
authors.affiliation: Division of Neuro Critical Care, Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, USA.
authors.forename: Atul Ashok
authors.initials: AA
authors.lastname: Kalanuria
authors.forename: Paul
authors.initials: P
authors.lastname: Nyquist
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Ling
mesh_terms: D000975:Antioxidants / Q000494:pharmacology; D050197:Atherosclerosis / Q000453:epidemiology / Q000503:physiopathology* / Q000517:prevention & control*; D003952:Diagnostic Imaging; D004032:Diet; D018450:Disease Progression; D011464:Epoprostenol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology; D015444:Exercise; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008403:Mass Screening; D009609:Nitrous Oxide / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D011322:Primary Prevention; D055502:Secondary Prevention
chemical_list: D000975:Antioxidants; D004967:Estrogens; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors; D011464:Epoprostenol; D009609:Nitrous Oxide